Olson Laurie J's Form 4/A amendment
AmendedKaruna Therapeutics, Inc. (KRTX) · filed Oct 12, 2022
- Accession no.
- 0001593968-22-001512
- Filed
- Oct 12, 2022
- Trade date
- Aug 15, 2022
- Filing delay
- 58 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Aug 16, 2022
This filing lists 1 derivative transaction. It carries over 2 transactions from the original filing that it did not restate. Open-market sales total $267.6K. It was filed 58 days after the trade.
This amendment restates part of 0001593968-22-001343 (filed Aug 16, 2022). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Olson Laurie JCIK 0001553231 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2022 | Common Stock | MOption exerciseDisposed | −1,000 | $0.00 | $0 | 17,000 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001593968-22-001343 (filed Aug 16, 2022).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2022 | Common Stock | MOption exerciseAcquired | +1,000 | $84.86 | +$84,860 | 1,000 | Direct | |
| Aug 15, 2022 | Common Stock | SSaleDisposed | −1,000 | $267.59 | −$267,590 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This option vests and becomes exercisable in thirty-six equal monthly installments beginning on August 12, 2020.
- F2
This Form 4/A amends the Form 4 filed by the reporting person on August 16, 2022 (the "Original Form 4"), which inadvertently reported the incorrect number of securities in column 9 of Table II. This Form 4/A is being filed solely to correct the number of securities reported in column 9 of Table II. No other amendments or changes have been made to the Original Form 4.